Bupropion Tablet, Film Coated, Extended Release
Product Images NDC 51655-357

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 51655-357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 357 26 Master Bottle Label Approval Rev A 05 20)

Label (51655 357 26 Master Bottle Label Approval   Rev A 05 20)
The text describes a medication identified by the NDC code 51655-357-26, which contains 90 tablets of Bupropion Hydrochloride at a strength of 150mg each. The tablets are in a dosage package and should be stored in temperatures not exceeding 30 degrees Celsius. The text also mentions "SR," which might refer to a sustained-release form of bupropion. There is an image included that is not readable, and there is no further information given.*
FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.